BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 26, 2006
View Archived Issues
Oscient Paying Reliant $78M For Cholesterol Drug In U.S.
Oscient Pharmaceuticals Inc. is gaining a piece of the fenofibrate market with its buyout of U.S. rights to the once-daily, cholesterol-lowering drug Antara from Reliant Pharmaceuticals Inc. for $78 million. (BioWorld Today)
Read More
Encysive's Shares Plunge On 2nd Thelin Approvable Letter
Read More
Momenta Surges On Potential $260M Sandoz Collaboration
Read More
Altus Falls After Reporting Delay In Phase III Programs
Read More
Following TGN1412 Fiasco, Revised Rules Suggested
Read More
Other News To Note
Read More
Clinic Roundup
Read More